Loading...

Marc Riedl

Title(s)Professor Of Clinical, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCLAClinical Immunology & Allergy Fellowship
    UCLA David Geffen School of Medicine, Los Angeles, CAMSClinical Research
    University of Chicago - Pritzker School of MedicineMD

    Collapse Overview 
    Collapse Overview
    Dr. Riedl is Clinical Director of the US HAEA Angiodema Center at the UC San Diego. His professional focus is on angiodema conditions and primary immunodeficiency, and clinical pharmacology.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet J Rare Dis. 2021 Feb 15; 16(1):86. PMID: 33588897.
      View in: PubMed   Mentions:    Fields:    
    2. Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies. Allergy Asthma Proc. 2021 Jan 21; 42(1):22-29. Johnston DT, Henry Li H, Craig TJ, Bernstein JA, Anderson J, Joseph K, Riedl MA. PMID: 33349293.
      View in: PubMed   Mentions: 1     Fields:    
    3. Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP Study. Allergy. 2020 Nov 30. Lumry WR, Weller K, Magerl M, Banerji A, Longhurst HJ, Riedl MA, Lewis HB, Lu P, Devercelli G, Jain G, Maurer M. PMID: 33258114.
      View in: PubMed   Mentions:    Fields:    
    4. A roadmap for optimal care of the patient with hereditary angioedema. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S01-S02. Castaldo AJ, Riedl MA, Settipane RA, Bellanti JA. PMID: 33109316.
      View in: PubMed   Mentions:    Fields:    
    5. Current medical management of hereditary angioedema: Follow-up survey of US physicians. Ann Allergy Asthma Immunol. 2020 Oct 26. Riedl MA, Banerji A, Gower R. PMID: 33122123.
      View in: PubMed   Mentions:    Fields:    
    6. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial. J Allergy Clin Immunol. 2020 Oct 21. Zuraw B, Lumry WR, Johnston DT, Aygören-Pürsün E, Banerji A, Bernstein JA, Christiansen SC, Jacobs JS, Sitz KV, Gower RG, Gagnon R, Wedner HJ, Kinaciyan T, Hakl R, Hanzlíková J, Anderson JT, McNeil DL, Fritz SB, Yang WH, Tachdjian R, Busse PJ, Craig TJ, Li HH, Farkas H, Best JM, Clemons D, Cornpropst M, Dobo SM, Iocca HA, Kargl D, Nagy E, Murray SC, Collis P, Sheridan WP, Maurer M, Riedl MA. PMID: 33098856.
      View in: PubMed   Mentions:    Fields:    
    7. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 Jan; 9(1):132-150.e3. Busse PJ, Christiansen SC, Riedl MA, Banerji A, Bernstein JA, Castaldo AJ, Craig T, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Zuraw BL. PMID: 32898710.
      View in: PubMed   Mentions:    Fields:    
    8. Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. Allergy. 2020 11; 75(11):2879-2887. Riedl MA, Maurer M, Bernstein JA, Banerji A, Longhurst HJ, Li HH, Lu P, Hao J, Juethner S, Lumry WR. PMID: 32452549.
      View in: PubMed   Mentions: 1     Fields:    
    9. Association Between Self-Reported Dental Hygiene Practices and Dental Procedure-Related Recurrent Angioedema Attacks in HAE Subjects: A Multicenter Survey. J Allergy Clin Immunol Pract. 2020 Oct; 8(9):3162-3169.e5. Singh U, Lumry WR, Busse P, Wedner HJ, Banerji A, Craig TJ, Li HH, Tachdjian R, Jacobs JS, Riedl MA, Davis-Lorton M, Christiansen SC, Zuraw BL, Bernstein JA. PMID: 32534150.
      View in: PubMed   Mentions:    Fields:    
    10. Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema. Ann Allergy Asthma Immunol. 2020 09; 125(3):334-340.e1. Bernstein JA, Schwartz L, Yang W, Baker J, Anderson J, Farkas H, Aygören-Pürsün E, Bygum A, Jacobs I, Feuersenger H, Pragst I, Riedl MA. PMID: 32445670.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Correction to: The International/Canadian Hereditary Angioedema Guideline. Allergy Asthma Clin Immunol. 2020; 16:33. Betschel S, Badiou J, Binkley K, Borici-Mazi R, Hébert J, Kanani A, Keith P, Lacuesta G, Waserman S, Yang B, Aygören-Pürsün E, Bernstein J, Bork K, Caballero T, Cicardi M, Craig T, Farkas H, Grumach A, Katelaris C, Longhurst H, Riedl M, Zuraw B, Berger M, Boursiquot JN, Boysen H, Castaldo A, Chapdelaine H, Connors L, Fu L, Goodyear D, Haynes A, Kamra P, Kim H, Lang-Robertson K, Leith E, McCusker C, Moote B, O'Keefe A, Othman I, Poon MC, Ritchie B, St-Pierre C, Stark D, Tsai E. PMID: 32399057.
      View in: PubMed   Mentions:
    12. Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence. Allergy. 2020 08; 75(8):2115-2123. Maurer M, Aberer W, Agondi R, Al-Ahmad M, Al-Nesf MA, Ansotegui I, Arnaout R, Arruda LK, Asero R, Aygören-Pürsün E, Banerji A, Bauer A, Ben-Shoshan M, Berardi A, Bernstein JA, Betschel S, Bindslev-Jensen C, Bizjak M, Boccon-Gibod I, Bork K, Bouillet L, Boysen HB, Brodszki N, Broesby-Olsen S, Busse P, Buttgereit T, Bygum A, Caballero T, Campos RA, Cancian M, Cherrez-Ojeda I, Cohn DM, Costa C, Craig T, Criado PR, Criado RF, Csuka D, Dissemond J, Du-Thanh A, Ensina LF, Ertas R, Fabiani JE, Fantini C, Farkas H, Ferrucci SM, Figueras-Nart I, Fili NL, Fomina D, Fukunaga A, Gelincik A, Giménez-Arnau A, Godse K, Gompels M, Gonçalo M, Gotua M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Ilina N, Inomata N, Jakob T, Josviack DO, Kang HR, Kaplan A, Kasperska-Zajac A, Katelaris C, Kessel A, Kleinheinz A, Kocatürk E, Košnik M, Krasowska D, Kulthanan K, Kumaran MS, Larco Sousa JI, Longhurst HJ, Lumry W, MacGinnitie A, Magerl M, Makris MP, Malbrán A, Marsland A, Martinez-Saguer I, Medina IV, Meshkova R, Metz M, Nasr I, Nicolay J, Nishigori C, Ohsawa I, Özyurt K, Papadopoulos NG, Parisi CAS, Peter JG, Pfützner W, Popov T, Prior N, Ramon GD, Reich A, Reshef A, Riedl MA, Ritchie B, Röckmann-Helmbach H, Rudenko M, Salman A, Sanchez-Borges M, Schmid-Grendelmeier P, Serpa FS, Serra-Baldrich E, Sheikh FR, Smith W, Soria A, Staubach P, Steiner UC, Stobiecki M, Sussman G, Tagka A, Thomsen SF, Treudler R, Valle S, van Doorn M, Varga L, Vázquez DO, Wagner N, Wang L, Weber-Chrysochoou C, Ye YM, Zalewska-Janowska A, Zanichelli A, Zhao Z, Zhi Y, Zuberbier T, Zwiener RD, Castaldo A. PMID: 32248571.
      View in: PubMed   Mentions:    Fields:    
    13. Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review. J Allergy Clin Immunol Pract. 2020 Jun; 8(6):1875-1880.e3. Brooks JP, Radojicic C, Riedl MA, Newcomer SD, Banerji A, Hsu FI. PMID: 32251736.
      View in: PubMed   Mentions:    Fields:    
    14. Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial. Allergy Asthma Clin Immunol. 2020; 16:8. Levy DS, Farkas H, Riedl MA, Hsu FI, Brooks JP, Cicardi M, Feuersenger H, Pragst I, Reshef A. PMID: 32042283.
      View in: PubMed   Mentions:
    15. The International/Canadian Hereditary Angioedema Guideline. Allergy Asthma Clin Immunol. 2019; 15:72. Betschel S, Badiou J, Binkley K, Borici-Mazi R, Hébert J, Kanani A, Keith P, Lacuesta G, Waserman S, Yang B, Aygören-Pürsün E, Bernstein J, Bork K, Caballero T, Cicardi M, Craig T, Farkas H, Grumach A, Katelaris C, Longhurst H, Riedl M, Zuraw B, Berger M, Boursiquot JN, Boysen H, Castaldo A, Chapdelaine H, Connors L, Fu L, Goodyear D, Haynes A, Kamra P, Kim H, Lang-Robertson K, Leith E, McCusker C, Moote B, O'Keefe A, Othman I, Poon MC, Ritchie B, St-Pierre C, Stark D, Tsai E. PMID: 31788005.
      View in: PubMed   Mentions:
    16. Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. Allergy Asthma Clin Immunol. 2019; 15:49. Li HH, Zuraw B, Longhurst HJ, Cicardi M, Bork K, Baker J, Lumry W, Bernstein J, Manning M, Levy D, Riedl MA, Feuersenger H, Prusty S, Pragst I, Machnig T, Craig T. PMID: 31485239.
      View in: PubMed   Mentions:
    17. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema. Clin Rev Allergy Immunol. 2019 Apr; 56(2):207-218. Henry Li H, Riedl M, Kashkin J. PMID: 29909591.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):1793-1802.e2. Craig T, Zuraw B, Longhurst H, Cicardi M, Bork K, Grattan C, Katelaris C, Sussman G, Keith PK, Yang W, Hébert J, Hanzlikova J, Staubach-Renz P, Martinez-Saguer I, Magerl M, Aygören-Pürsün E, Farkas H, Reshef A, Kivity S, Neri S, Crisan I, Caballero T, Baeza ML, Hernandez MD, Li H, Lumry W, Bernstein JA, Hussain I, Anderson J, Schwartz LB, Jacobs J, Manning M, Levy D, Riedl M, Christiansen S, Feuersenger H, Pragst I, Mycroft S, Pawaskar D, Jacobs I. PMID: 30772477.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    19. Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies. BioDrugs. 2019 Feb; 33(1):33-43. Busse PJ, Farkas H, Banerji A, Lumry WR, Longhurst HJ, Sexton DJ, Riedl MA. PMID: 30539362.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1610-1618.e4. Lumry WR, Martinez-Saguer I, Yang WH, Bernstein JA, Jacobs J, Moldovan D, Riedl MA, Johnston DT, Li HH, Tang Y, Schranz J, Lu P, Vardi M, Farkas H. PMID: 30682573.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):2035-2038. Craig T, Lumry W, Cicardi M, Zuraw B, Bernstein JA, Anderson J, Jacobs J, Riedl MA, Manning ME, Banerji A, Gower RG, Caballero T, Farkas H, Feuersenger H, Jacobs I, Machnig T, Longhurst H. PMID: 30660873.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    22. Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. JAMA. 2018 11 27; 320(20):2108-2121. Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL, Busse PJ, Anderson J, Magerl M, Martinez-Saguer I, Davis-Lorton M, Zanichelli A, Li HH, Craig T, Jacobs J, Johnston DT, Shapiro R, Yang WH, Lumry WR, Manning ME, Schwartz LB, Shennak M, Soteres D, Zaragoza-Urdaz RH, Gierer S, Smith AM, Tachdjian R, Wedner HJ, Hebert J, Rehman SM, Staubach P, Schranz J, Baptista J, Nothaft W, Maurer M. PMID: 30480729.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    23. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States. Orphanet J Rare Dis. 2018 10 12; 13(1):180. Riedl MA, Banerji A, Manning ME, Burrell E, Joshi N, Patel D, Machnig T, Tai MH, Watson DJ. PMID: 30314518.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema. Clin Exp Allergy. 2018 10; 48(10):1325-1332. Pawaskar D, Tortorici MA, Zuraw B, Craig T, Cicardi M, Longhurst H, Li HH, Lumry WR, Martinez-Saguer I, Jacobs J, Bernstein JA, Riedl MA, Katelaris CH, Keith PK, Feussner A, Sidhu J. PMID: 29998524.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    25. Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema. Clin Exp Allergy. 2018 11; 48(11):1429-1438. Lara-Marquez ML, Christiansen SC, Riedl MA, Herschbach J, Zuraw BL. PMID: 29957871.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency. Ann Allergy Asthma Immunol. 2018 12; 121(6):673-679. Craig T, Busse P, Gower RG, Johnston DT, Kashkin JM, Li HH, Lumry WR, Riedl MA, Soteres D. PMID: 30056152.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks. Allergy Asthma Proc. 2018 Sep 28; 39(5):359-364. Baker JW, Bernstein JA, Harper JR, Relan A, Riedl MA. PMID: 29954477.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Hereditary angioedema from the patient's perspective: A follow-up patient survey. Allergy Asthma Proc. 2018 May 01; 39(3):212-223. PMID: 29669666.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply. Lancet. 2018 04 07; 391(10128):1356. Riedl MA, Relan A, Harper JR, Cicardi M. PMID: 29636270.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1733-1741.e3. Lumry WR, Craig T, Zuraw B, Longhurst H, Baker J, Li HH, Bernstein JA, Anderson J, Riedl MA, Manning ME, Keith PK, Levy DS, Caballero T, Banerji A, Gower RG, Farkas H, Lawo JP, Pragst I, Machnig T, Watson DJ. PMID: 29391286.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    31. An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension. Clin Transl Allergy. 2017; 7:36. PMID: 29043014.
      View in: PubMed   Mentions:
    32. Vedolizumab in Patients With Common Variable Immune Deficiency and Gut Inflammation. Am J Gastroenterol. 2017 10; 112(10):1621. Boland BS, Riedl MA, Valasek MA, Crowe SE, Sandborn WJ. PMID: 28978958.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement. Allergy Asthma Proc. 2017 Nov 13; 38(6):462-466. Riedl MA, Li HH, Cicardi M, Harper JR, Relan A. PMID: 28903805.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    34. Emerging Therapies in Hereditary Angioedema. Immunol Allergy Clin North Am. 2017 08; 37(3):585-595. PMID: 28687111.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    35. Angioedema: Challenges and Insights. Immunol Allergy Clin North Am. 2017 08; 37(3):xv-xvi. PMID: 28687115.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. Lancet. 2017 Sep 30; 390(10102):1595-1602. Riedl MA, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M. PMID: 28754491.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    37. Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation. Ann Allergy Asthma Immunol. 2017 09; 119(3):258-261. Geng B, Eastman JJ, Mori K, Braskett M, Riedl MA. PMID: 28743423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States. Ann Allergy Asthma Immunol. 2017 07; 119(1):59-64. PMID: 28668241.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    39. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med. 2017 03 23; 376(12):1131-1140. PMID: 28328347.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    40. Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1142-1145. PMID: 28286153.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks. Ann Allergy Asthma Immunol. 2017 04; 118(4):452-455. PMID: 28284978.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017 Mar 01; 8(1):13-19. PMID: 28381322.
      View in: PubMed   Mentions:
    43. Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. 2017 02 23; 376(8):717-728. PMID: 28225674.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    44. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1091-1097. PMID: 28202404.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    45. Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry. Ann Allergy Asthma Immunol. 2017 01; 118(1):110-112. PMID: 27865714.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    46. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility. J Allergy Clin Immunol Pract. 2017 Mar - Apr; 5(2):442-447.e1. PMID: 27818136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. Allergy Asthma Proc. 2016 Nov; 37(6):489-500. PMID: 27931305.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    48. Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. Pediatrics. 2016 11; 138(5). PMID: 27940765.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):128-134.e4. PMID: 27665386.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):963-71. PMID: 27286778.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    51. Cases of acquired C1 inhibitor deficiency treated with rituximab. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):987-8. PMID: 27130715.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Managing the female patient with hereditary angioedema. Womens Health (Lond). 2016 06; 12(3):351-61. PMID: 26978558.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3. Int Arch Allergy Immunol. 2015; 168(1):44-55. PMID: 26556097.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    54. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema. Clin Drug Investig. 2015 Jul; 35(7):407-17. PMID: 26091744.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol. 2015 Jul; 115(1):33-8. PMID: 25959032.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Current state of hereditary angioedema management: a patient survey. Allergy Asthma Proc. 2015 May-Jun; 36(3):213-7. PMID: 25976438.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    57. Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedema. Allergy Asthma Proc. 2015 May-Jun; 36(3):206-12. PMID: 25803135.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    58. Before and after, the impact of available on-demand treatment for HAE. Allergy Asthma Proc. 2015 Mar-Apr; 36(2):145-50. PMID: 25715243.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    59. Critical appraisal of androgen use in hereditary angioedema: a systematic review. Ann Allergy Asthma Immunol. 2015 Apr; 114(4):281-288.e7. PMID: 25707325.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    60. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2015 May-Jun; 3(3):417-23. PMID: 25680925.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    61. Facilitating home-based treatment of hereditary angioedema. Allergy Asthma Proc. 2015 Mar-Apr; 36(2):92-9. PMID: 25551795.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. Current medical management of hereditary angioedema: follow-up survey of US physicians. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):220-7. PMID: 25609328.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):206-212.e4. PMID: 25609335.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):200-5. PMID: 25609336.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. The therapeutic landscape for hereditary angioedema: more change on the horizon? Ann Allergy Asthma Immunol. 2014 Oct; 113(4):337-8. PMID: 25256026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014 Apr; 21(4):469-84. PMID: 24730413.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    67. Reply: To PMID 24565612. J Allergy Clin Immunol Pract. 2014 Mar-Apr; 2(2):239-40. PMID: 24607059.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2014 Feb; 112(2):163-169.e1. PMID: 24468257.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCTClinical Trials
    69. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema. Am J Rhinol Allergy. 2013 Nov-Dec; 27(6):517-21. PMID: 24274230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):458-67. PMID: 24565617.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    71. Creating a comprehensive treatment plan for hereditary angioedema. Immunol Allergy Clin North Am. 2013 Nov; 33(4):471-85. PMID: 24176212.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    72. Hereditary angioedema with normal C1-INH (HAE type III). J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):427-32. PMID: 24565612.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Ann Allergy Asthma Immunol. 2013 Apr; 110(4):295-9. PMID: 23535096.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    74. Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women. Allergy Asthma Proc. 2013 Mar-Apr; 34(2):162-9. PMID: 23484892.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    75. Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study. Allergy Asthma Proc. 2013 Mar-Apr; 34(2):155-61. PMID: 23484891.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    76. Analysis of hereditary angioedema attacks requiring a second dose of ecallantide. Ann Allergy Asthma Immunol. 2013 Mar; 110(3):168-72. PMID: 23548526.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    77. HAE update: special considerations in the female patient with hereditary angioedema. Allergy Asthma Proc. 2013 Jan-Feb; 34(1):13-8. PMID: 23406930.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    78. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012 Nov-Dec; 33 Suppl 1:S145-56. PMID: 23394603.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    79. Hereditary angioedema: implications of treating a rare disease. Ann Allergy Asthma Immunol. 2012 Aug; 109(2):150-1; author reply 151. PMID: 22840260.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Clin Ther. 2012 Mar; 34(3):623-30. PMID: 22386830.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    81. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Ann Allergy Asthma Immunol. 2012 Jan; 108(1):49-53. PMID: 22192966.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    82. Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol. 2011 Dec; 107(6):529-37. PMID: 22123383.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    83. Meeting the challenges and burdens associated with hereditary angioedema. Manag Care. 2011 Sep; 20(9):44-51. PMID: 21991862.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. New therapeutics in C1INH deficiency: a review of recent studies and advances. Curr Allergy Asthma Rep. 2011 Aug; 11(4):300-8. Parikh N, Riedl MA. PMID: 21607669.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    85. Current medical management of hereditary angioedema: results from a large survey of US physicians. Ann Allergy Asthma Immunol. 2011 Apr; 106(4):316-322.e4. Riedl M, Gower RG, Chrvala CA. PMID: 21457880.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    86. Update on the acute treatment of hereditary angioedema. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):11-6. Riedl MA. PMID: 21262093.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. Response time for ecallantide treatment of acute hereditary angioedema attacks. Ann Allergy Asthma Immunol. 2010 Dec; 105(6):430-436.e2. Riedl M, Campion M, Horn PT, Pullman WE. PMID: 21130380.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    88. Introduction: New Perspectives in Hereditary Angioedema (HAE): Molecular Mechanisms & Therapeutic Choices: A CME Symposium Presented at the 2009 World Allergy Congress, Buenos Aires, Argentina, December 9, 2009. World Allergy Organ J. 2010 Sep; 3(9 Suppl):S24. PMID: 23282865.
      View in: PubMed   Mentions:
    89. Hereditary angioedema therapy: kallikrein inhibition and bradykinin receptor antagonism. World Allergy Organ J. 2010 Sep; 3(9 Suppl):S34-8. PMID: 23282868.
      View in: PubMed   Mentions:
    90. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010 Aug 05; 363(6):532-41. Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT. PMID: 20818888.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCTClinical Trials
    91. Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol. 2010; 152(4):313-8. Lin E, Saxon A, Riedl M. PMID: 20185923.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    92. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol. 2009 May; 102(5):366-72. Craig T, Riedl M, Dykewicz MS, Gower RG, Baker J, Edelman FJ, Hurewitz D, Jacobs J, Kalfus I. PMID: 19492656.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    93. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin Immunol. 2009 Mar; 130(3):244-51. Riedl MA, Saxon A, Diaz-Sanchez D. PMID: 19028145.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    94. The effect of air pollution on asthma and allergy. Curr Allergy Asthma Rep. 2008 Apr; 8(2):139-46. Riedl MA. PMID: 18417056.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    95. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol. 2008 Feb; 8(1):49-56. Riedl MA, Nel AE. PMID: 18188018.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    96. Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen. J Immunol. 2005 Jun 01; 174(11):7440-5. Riedl MA, Landaw EM, Saxon A, Diaz-Sanchez D. PMID: 15905593.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    97. Biology of diesel exhaust effects on respiratory function. J Allergy Clin Immunol. 2005 Feb; 115(2):221-8; quiz 229. Riedl M, Diaz-Sanchez D. PMID: 15696072.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimals
    98. Adverse drug reactions: types and treatment options. Am Fam Physician. 2003 Nov 01; 68(9):1781-90. Riedl MA, Casillas AM. PMID: 14620598.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    Marc's Networks
    Concepts (252)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑